Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases
Abstract NMDAR antagonists, such as memantine and ketamine, have shown efficacy in treating neurodegenerative diseases and major depression. The mechanism by which these drugs correct the aforementioned diseases is still unknown. Our study reveals that these antagonists significantly enhance 20S pro...
Saved in:
Main Authors: | Fikret Sahin, Aslihan Gunel, Buse Turegun Atasoy, Ulku Guler, Bekir Salih, Isinsu Kuzu, Mehmet Taspinar, Ozgur Cinar, Selda Kahveci |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-84479-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease
by: Taylor R. Church, et al.
Published: (2025-02-01) -
Autoimmune encephalitis: case reports of anti-NMDAR and anti-CASPR2 encephalitides and literature review
by: J. Kazlauskaitė, et al.
Published: (2021-12-01) -
Molecular insights into the unique properties of the blood‐circulating proteasome
by: Yegor Leushkin, et al.
Published: (2025-01-01) -
Structural comparison of human and Plasmodium proteasome β5 subunits: informing selective inhibitor design for anti-malaria agents
by: Muhammad Yasir, et al.
Published: (2025-01-01) -
Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno)proteasome
by: Gobec Martina, et al.
Published: (2023-09-01)